Fig. 3.

Response (efficacy population^a)

(A) Proportion of patients achieving clinical response according to ACR20, ACR50 and ACR70 criteria. (B) Proportion of patients with good/moderate response according to EULAR (CRP) and EULAR (ESR).

^aFrom W30 to W54, all patients received CT-P13 s.c. and are analysed according to treatment received prior to W30.

^bAt W6, patients were randomized to treatment; efficacy results up to W6 represent the efficacy of CT-P13 i.v. loading dose, regardless of randomized arm.

ACR20, 20% improvement in ACR criteria; ACR50, 50% improvement in ACR criteria; ACR70, 70% improvement in ACR criteria; W, week.